propafenone has been researched along with Edema, Pulmonary in 2 studies
Propafenone: An antiarrhythmia agent that is particularly effective in ventricular arrhythmias. It also has weak beta-blocking activity.
propafenone : An aromatic ketone that is 3-(propylamino)propane-1,2-diol in which the hydrogen of the primary hydroxy group is replaced by a 2-(3-phenylpropanoyl)phenyl group. It is a class 1C antiarrhythmic drug with local anesthetic effects, and is used as the hydrochloride salt in the management of supraventricular and ventricular arrhythmias.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nawrocka, I | 1 |
| Kaczyńska, A | 1 |
| Abramczyk, P | 1 |
| Kolettis, TM | 1 |
| Naka, KK | 1 |
| Katsouras, C | 1 |
| Michalis, LK | 1 |
| Bourantas, K | 1 |
2 other studies available for propafenone and Edema, Pulmonary
| Article | Year |
|---|---|
Electric cardioversion of atrial fibrillation resulting in pulmonary oedema in patient with apical hypertrophic cardiomyopathy.
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiomyopathy, Hypertrophic; Diuretics; Electric Count | 2015 |
Transient intraventricular conduction delay associated with concurrent intake of propafenone and antineoplastic agents.
Topics: Acute Disease; Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Antineoplastic Agents; Drug Interact | 2003 |